Innoviva (INVA) Current Assets (2010 - 2026)
Innoviva (INVA) posted Current Assets of $772.6 million for Q1 2026, up 6.2% on a QoQ basis from $727.5 million in Q4 2025, and up 32.75% year-over-year from $582.0 million in Q1 2025.
Innoviva (INVA) Current Assets (2010 - 2026) Analysis & Trends
Innoviva's Current Assets history runs 17 years deep, the most recent figure standing at $772.6 million for Q1 2026.
- Quarterly Current Assets rose 32.75% year-over-year to $772.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $772.6 million (up 32.75% YoY) and the FY2025 annual result came in at $727.5 million, up 31.25% from the prior year.
- Current Assets was $772.6 million for Q1 2026 at Innoviva, up from $727.5 million in the prior quarter.
- Across five years, Current Assets topped out at $772.6 million in Q1 2026 and bottomed at $16.9 million in Q3 2025.
- A 5-year average of $364.3 million and a median of $344.2 million in 2023 frame the typical range for Current Assets.
- Annual changes were most pronounced in 2022 — Current Assets soared 170.02% — and 2024, when it tumbled 38.8%.
- Innoviva's Current Assets stood at $443.5 million in 2022, then slipped by 22.39% to $344.2 million in 2023, then surged by 61.03% to $554.3 million in 2024, then jumped by 31.25% to $727.5 million in 2025, then advanced by 6.2% to $772.6 million in 2026.
- Business Quant data shows INVA's Current Assets at $772.6 million in Q1 2026, $727.5 million in Q4 2025, and $16.9 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 289.93 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 73.04 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 6.60 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 35.73 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 11.73 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 18.21 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 521.86 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 8.07 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 1.97 Bn |
| 10 | Innoviva | 1.57 Bn | 969.11 Mn | 75.83 Mn | 772.62 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 772.62 Mn |
| Dec 31, 2025 | 727.52 Mn |
| Sep 30, 2025 | 16.93 Mn |
| Jun 30, 2025 | 651.78 Mn |
| Mar 31, 2025 | 582.02 Mn |
| Dec 31, 2024 | 554.31 Mn |
| Sep 30, 2024 | 22.39 Mn |
| Jun 30, 2024 | 358.28 Mn |
| Mar 31, 2024 | 311.34 Mn |
| Dec 31, 2023 | 344.22 Mn |
| Sep 30, 2023 | 36.59 Mn |
| Jun 30, 2023 | 323.54 Mn |
| Mar 31, 2023 | 296.45 Mn |
| Dec 31, 2022 | 443.51 Mn |
| Sep 30, 2022 | 33.25 Mn |
| Jun 30, 2022 | 400.33 Mn |
| Mar 31, 2022 | 317.82 Mn |
| Dec 31, 2021 | 313.67 Mn |
| Sep 30, 2021 | 49.75 Mn |
| Jun 30, 2021 | 148.26 Mn |